Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2015-01-20484,2015,Kourlaba 2015 BMC Health Serv Res,6700,Ranolazine as add-on treatment VERSUS Standard/Usual Care- Standard care for stable angina IN Specific disease- Chronic angina pectarisin; Age- Adult; Gender- Both; Country- Greece.,26684327,Specific disease- Chronic angina pectarisin; Age- Adult; Gender- Both; Country- Greece.,Ranolazine as add-on treatment,Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.,Standard/Usual Care- Standard care for stable angina,NE
2015-01-17524,2015,Kourlaba 2015 BMC Health Serv Res,Cost-Saving,Everolimus plus exemestane VERSUS Bevacizumab-based chemotherapy: bevacizumab + capecitabine IN Specific disease- Hormone receptor-positive metastatic breast cancer; Age- Adult; Gender- Female; Country- Greece.,26239115,Specific disease- Hormone receptor-positive metastatic breast cancer; Age- Adult; Gender- Female; Country- Greece.,Everolimus plus exemestane,Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line  treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study.,Bevacizumab-based chemotherapy: bevacizumab + capecitabine,SE
2015-01-17524,2015,Kourlaba 2015 BMC Health Serv Res,Cost-Saving,Everolimus plus exemestane VERSUS Bevacizumab-based chemotherapy: bevacizumab + paclitaxel IN Specific disease- Hormone receptor-positive metastatic breast cancer; Age- Adult; Gender- Female; Country- Greece.,26239115,Specific disease- Hormone receptor-positive metastatic breast cancer; Age- Adult; Gender- Female; Country- Greece.,Everolimus plus exemestane,Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line  treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study.,Bevacizumab-based chemotherapy: bevacizumab + paclitaxel,SE
2014-01-17001,2014,Kourlaba 2014 Cost Eff Resour Alloc,Cost-Saving,Rivaroxaban VERSUS Vitamin-K-antagonists (VKAs) IN Specific disease- Non-valvular atrial fibrillation (AF); Age- Adult; Gender- Both; Country- Greece.,24512351,Specific disease- Non-valvular atrial fibrillation; Age- Adult; Gender- Both; Country- Greece.,Rivaroxaban,Economic evaluation of rivaroxaban in stroke prevention for patients with atrial  fibrillation in Greece.,Vitamin-K-antagonists (VKAs),SE
2014-01-15835,2014,Tzanetakos 2014 BMC Health Serv Res,10000,Liraglutide VERSUS Exenatide BID IN Specific disease- Type 2 diabetes; Age- Unknown; Gender- Not Specified; Country- Greece.,25245666,Specific disease- Type 2 diabetes; Age- Unknown; Gender- Not Specified; Country- Greece.,Liraglutide,Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs  in Greece.,Exenatide BID,NE
2014-01-15835,2014,Tzanetakos 2014 BMC Health Serv Res,22000,Liraglutide VERSUS Sitagliptin IN Specific disease- Type 2 diabetes; Age- Unknown; Gender- Not Specified; Country- Greece.,25245666,Specific disease- Type 2 diabetes; Age- Unknown; Gender- Not Specified; Country- Greece.,Liraglutide,Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs  in Greece.,Sitagliptin,NE
2014-01-15481,2014,McCann 2014 Gynecol Oncol,Cost-Saving,"Radical vulvectomy and sentinel lymph node biopsy VERSUS Radical vulvectomy + universal inguinofemoral lymphadenectomy (LND) IN Specific disease- Early-stage vulvar cancer; Age- Unknown; Gender- Female; Country- United States; Other- Newly diagnosed, early-stage vulvar cancer.",25478927,"Specific disease- Early-stage vulvar cancer; Age- Unknown; Gender- Female; Country- United States; Other- Newly diagnosed, early-stage vulvar cancer.",Radical vulvectomy and sentinel lymph node biopsy,Lymphatic mapping and sentinel lymph node dissection compared to complete lymphadenectomy in the management of early-stage vulvar cancer: A cost-utility analysis.,Radical vulvectomy + universal inguinofemoral lymphadenectomy (LND),SE
2014-01-15424,2014,Kourlaba 2014 BMC Health Serv Res,15000,Ivabradine plus standard of care VERSUS Standard/Usual Care IN Specific disease- Chronic Heart Failure; Age- Adult; Gender- Both; Country- Greece.,25496716,Specific disease- Chronic Heart Failure; Age- Adult; Gender- Both; Country- Greece.,Ivabradine plus standard of care,Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece.,Standard/Usual Care,NE
2013-01-15118,2013,Demaerschalk 2013 Am J Manag Care,Cost-Saving,Managing acute ischemic stroke (AIS) with a telestroke network: a hub-and-spoke telestroke network (1 hub and 7 spokes) VERSUS Standard/Usual Care IN Specific disease- acute ischemic stroke; Age- Unknown; Gender- Not Specified; Country- United States.,24512034,Specific disease- acute ischemic stroke; Age- Unknown; Gender- Not Specified; Country- United States.,Managing acute ischemic stroke (AIS) with a telestroke network: a hub-and-spoke telestroke network (1 hub and 7 spokes),Cost utility of hub-and-spoke telestroke networks from societal perspective.,Standard/Usual Care,SE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,2100,Agomelatine VERSUS Generic Venlafaxine IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Generic Venlafaxine,NE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,4800,Agomelatine VERSUS Generic Escitalopram IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Generic Escitalopram,NE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,790,Agomelatine VERSUS Venlafaxine IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Venlafaxine,NE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,Cost-Saving,Agomelatine VERSUS Escitalopram IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Escitalopram,SE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,Cost-Saving,Agomelatine VERSUS Fluoxetine generic IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Fluoxetine generic,SE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,Cost-Saving,Agomelatine VERSUS Fluoxetine IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Fluoxetine,SE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,Cost-Saving,Agomelatine VERSUS Generic Sertraline IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Generic Sertraline,SE
2013-01-11342,2013,Maniadakis 2013 BMC Health Serv Res,Cost-Saving,Agomelatine VERSUS Sertraline IN Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,23663281,Specific disease- major depressive disorders; Age- Adult; Gender- Both; Country- Greece.,Agomelatine,Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece.,Sertraline,SE
2013-01-10800,2013,Sgourakis 2013 Surg Endosc,5900,Laparoscopic totally extraperitoneal hernia repair (TEP) VERSUS Open preperitoneal mesh repair according to Nyhus procedure (incorporating a preperitoneal prosthetic mesh + approximation of the transversalis fascia to Cooper’s ligament) IN Specific disease- inguinal hernia; Age- Adult; Gender- Both; Country- Greece; Other- recurrent.,23344511,Specific disease- inguinal hernia; Age- Adult; Gender- Both; Country- Greece; Other- recurrent.,Laparoscopic totally extraperitoneal hernia repair (TEP),Laparoscopic totally extraperitoneal versus open preperitoneal mesh repair for inguinal hernia recurrence: a decision analysis based on net health benefits.,Open preperitoneal mesh repair according to Nyhus procedure (incorporating a preperitoneal prosthetic mesh + approximation of the transversalis fascia to Cooper’s ligament),NE
2013-01-10800,2013,Sgourakis 2013 Surg Endosc,Dominated,Open preperitoneal mesh repair according to Stoppa procedure (integrated the use of mesh) VERSUS Open preperitoneal mesh repair according to Nyhus procedure (incorporating a preperitoneal prosthetic mesh + approximation of the transversalis fascia to Cooper’s ligament) IN Specific disease- inguinal hernia; Age- Adult; Gender- Both; Country- Greece; Other- recurrent.,23344511,Specific disease- inguinal hernia; Age- Adult; Gender- Both; Country- Greece; Other- recurrent.,Open preperitoneal mesh repair according to Stoppa procedure (integrated the use of mesh),Laparoscopic totally extraperitoneal versus open preperitoneal mesh repair for inguinal hernia recurrence: a decision analysis based on net health benefits.,Open preperitoneal mesh repair according to Nyhus procedure (incorporating a preperitoneal prosthetic mesh + approximation of the transversalis fascia to Cooper’s ligament),NW
2012-01-09568,2012,Kourlaba 2012 Appl Health Econ Health Policy,7000,"Clopidogrel (treatment effect only last 2 years within the Markov model) VERSUS Aspirin IN Patients with atherothrombosis with peripheral arterial disease, a recent ischemic stroke, or a recent myocardial infarction in Greece",22853743,"Patients with atherothrombosis with peripheral arterial disease, a recent ischemic stroke, or a recent myocardial infarction in Greece",Clopidogrel (treatment effect only last 2 years within the Markov model),Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece.,Aspirin,NE
1 2 3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
